Skip to content
Disability, Medical Health Aged Care

Aphasia recovery professor scoops international award

La Trobe University 2 mins read

A La Trobe professor has been awarded the Robin Tavistock 2024 award for her important contribution to the field of aphasia, a significant communication disability following stroke and other brain injuries where people can have difficulty speaking, reading, writing, and understanding language and numbers.

Professor Miranda Rose, Director of La Trobe’s Centre of Research Excellence in Aphasia Recovery and Rehabilitation, received the prestigious award presented annually to a person or group who has made a significant international contribution to the field of aphasia.

The award is named after Robin Tavistock, the 14th Duke of Bedford who founded The Tavistock Trust for Aphasia.

“I feel honoured and very humbled to receive this international award – it reflects the hard work and generous collaboration of the many national and international researchers, clinicians, and people with lived experience of communication disability that I have been so fortunate to work with,” Professor Rose said.

Professor Rose, who set up the Centre in 2019, was lead investigator in the largest comparison trial of aphasia rehabilitation to date, which examined outcomes from constraint-induced and multi-modality aphasia treatments.

The team found that the intervention they developed, called Multi-modality Aphasia Therapy (M-MAT), was more effective than constraint therapy and usual care for improving quality of life for people with aphasia following a stroke. M-MAT is provided by a speech pathologist in small groups of people with aphasia.

Following the trial M-MAT is being developed for telehealth delivery. M-MAT has been successfully trialled in Canada and Japan and will soon be trialled in Brazil.

Professor Rose and her co-design team created the new Communication Connect web platform, which helps people living with aphasia and communication disabilities after traumatic brain injury to communicate better and live well once they leave rehabilitation programs.

The Communication Connect web platform is AI enabled so solutions to challenges can be personalised and customised to the user’s needs. The platform will undergo a pilot trial through Bendigo Health this year.

Professor Rose said the platform contained information about rehabilitation and self-management options, links to apps for self-managed communication therapy and bespoke solutions such as a mood tracker that can support the person to track their mood and aims to reduce the possibility of developing depression or social isolation.


Contact details:

Elaine Cooney
[email protected]
0487 448 734

More from this category

  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

  • Medical Health Aged Care, Political
  • 10/04/2026
  • 09:25
McKell Institute

Australians skipping doses, taking expired medication as prices balloon despite ‘Cheaper Medicines’

Australians are skipping doses, taking expired medication and going without groceries to afford medicines prescribed by their doctors because they aren’t covered by Labor’s landmark Cheaper Medicines policy, new research from the McKell Institute has revealed. McKell’s new report Still Out of Pocket found 43 per cent of Australians have been prescribed medicines which aren’t on the PBS. The Cheaper Medicines policy only covers medicines listed on the PBS. 24 per cent of all people prescribed medicines outside the PBS do not purchase the medicine at all, while 16 per cent say they are forced to go without essentials, like…

  • Medical Health Aged Care
  • 10/04/2026
  • 09:00
Neuroscience Research Australia (NeuRA)

EXPERT ALERT: ‘Bridge the Gap’ this World Parkinson’s Day

One Aussie is diagnosed with Parkinson’s Disease every 40 minutes. It’s the fastest growing neurological condition in the world and the second most common in Australia, after dementia. World Parkinson’s Day on 11 April aims to raise awareness of the disease, reduce stigma and advocate for better care and research support. Neuroscience Research Australia (NeuRA) has a team of experts, including clinician researchers, working to improve our understanding, diagnosis and treatment of Parkinson’s. They are available to speak on the importance of World Parkinson’s Day, providing comment on: Current research projects Improving understanding of Parkinson’s Disease, including its symptoms and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.